Screening compound: C20H24N2O2S (S430-0213)

Screening compound: C<sub>20</sub>H<sub>24</sub>N<sub>2</sub>O<sub>2</sub>S (S430-0213)
Screening compound: C<sub>20</sub>H<sub>24</sub>N<sub>2</sub>O<sub>2</sub>S (S430-0213) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C20H24N2O2S (S430-0213)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S430-0213

Molecular Formula

C20H24N2O2S (C20 H24 N2 O2 S)

Compound Name

N-(cyclopropylmethyl)-3-({1-[(3-methylthiophen-2-yl)methyl]azetidin-3-yl}oxy)benzamide

IUPAC name

N-(cyclopropylmethyl)-3-({1-[(3-methylthiophen-2-yl)methyl]azetidin-3-yl}oxy)benzamide

SMILES

Cc1c(CN(C2)CC2Oc2cc(C(NCC3CC3)=O)ccc2)scc1

InChI

InChI=1S/C20H24N2O2S/c1-14-7-8-25-19(14)13-22-11-18(12-22)24-17-4-2-3-16(9-17)20(23)21-10-15-5-6-15/h2-4,7-9,15,18H,5-6,10-13H2,1H3,(H,21,23)

InChI Key

ZZODJEWCLBHVHJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29007529

C20H24N2O2S (S430-0213) in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

GPCR Targeted Library (31838 compounds)

Ligand-Gated Ion Channels Library (3887 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Mimetics
  • Mimetics
  • Cyclic compounds
Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Nervous system
  • Eye
  • Nervous system
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • GPCR
  • Ion Channels
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic

References: we are preparing a list of scientific research reports with C20H24N2O2S (S430-0213) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C20H24N2O2S (S430-0213)?
Check Price and Availability of C20H24N2O2S (S430-0213), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C20H24N2O2S (S430-0213) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C20H24N2O2S (S430-0213)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C20H24N2O2S (S430-0213)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C20H24N2O2S (S430-0213) available by request